Singapore

Goh Meng Seng’s post about MOH-sponsored study on Lianhua Qingwen medicine for COVID-19 ‘incorrect’: Health Ministry


SINGAPORE: A Facebook post by People’s Power Party politician Goh Meng Seng stating that the Ministry of Health (MOH) had sponsored a study on Chinese medicine Lianhua Qingwen for COVID-19 therapy is “incorrect”, mentioned the Health Ministry on Sunday (Nov 21).  Mr Goh had mentioned in his post that MOH sponsored a study, which was alleged to run from July 2020 to February 2021, on the efficacy of Lianhua Qingwen in treating gentle COVID-19 infections, the ministry mentioned. Mr Goh additionally requested why the findings of the study had not been revealed, and accused the Government of mendacity, the ministry added. MOH had certainly provided to sponsor the study underneath a conventional Chinese medicine analysis grant, the ministry mentioned on Sunday. However, the principal investigator for the study later withdrew her utility as she was unable to safe an acceptable study website, it added. “Mr Goh Meng Seng’s post is incorrect,” mentioned MOH. “Mr Goh Meng Seng has accused the Government of lying; this is a serious, baseless accusation. We reserve the right to take further action if Mr Goh Meng Seng persists with this unjustified claim.” To date, a couple of randomised management medical trials on Lianhua Qingwen have been carried out solely in China, mentioned MOH. The numbers of sufferers in these trials weren’t massive sufficient, and there’s “no conclusive scientific evidence” to point out the medicine might be used to forestall or deal with COVID-19 in Singapore, it added. 

LIANHUA QINGWEN NOT APPROVED FOR TREATING COVID-19 SYMPTOMS

The Health Sciences Authority (HSA) mentioned earlier this week that Lianhua Qingwen has not been permitted for treating COVID-19 signs.  HSA mentioned it was conscious of claims circulating on social media and in Telegram discussion groups that Lianhua Qingwen merchandise might be used to forestall or deal with COVID-19. “Some Lianhua Qingwen products are listed as Chinese proprietary medicines in Singapore for the relief of cold and flu symptoms. HSA approved them based on the documented uses of the ingredients present in the products,” mentioned the authority. “To date, there is no scientific evidence from randomised clinical trials to show that any herbal product, including Lianhua Qingwen products, can be used to prevent or treat COVID-19.”



Download Now
Stay Tuned with Sociallykeeda.com for more Entertainment information.

- Advertisement-

Socially Keeda

Socially Keeda, the pioneer of news sources in India operates under the philosophy of keeping its readers informed. SociallyKeeda.com tells the story of India and it offers fresh, compelling content that’s useful and informative for its readers.
Back to top button

Adblock Detected

Please consider supporting us by disabling your ad blocker